Bioadaptives (BDPT) Gross Profit (2016 - 2025)
Bioadaptives' Gross Profit history spans 7 years, with the latest figure at $7583.0 for Q4 2025.
- On a quarterly basis, Gross Profit changed N/A to $7583.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $12497.0, a 210.1% increase, with the full-year FY2025 number at $12497.0, up 210.1% from a year prior.
- Gross Profit hit $7583.0 in Q4 2025 for Bioadaptives, up from $3851.0 in the prior quarter.
- Over the last five years, Gross Profit for BDPT hit a ceiling of $7583.0 in Q4 2025 and a floor of $429.0 in Q2 2024.
- Historically, Gross Profit has averaged $2622.2 across 5 years, with a median of $2153.0 in 2022.
- Biggest five-year swings in Gross Profit: soared 2180.27% in 2021 and later plummeted 71.21% in 2024.
- Tracing BDPT's Gross Profit over 5 years: stood at $1142.0 in 2021, then decreased by 9.81% to $1030.0 in 2022, then surged by 162.04% to $2699.0 in 2023, then plummeted by 84.11% to $429.0 in 2024, then skyrocketed by 1667.6% to $7583.0 in 2025.
- Business Quant data shows Gross Profit for BDPT at $7583.0 in Q4 2025, $3851.0 in Q3 2025, and $1063.0 in Q2 2025.